Zaxine · DIN 02410702 · 550 mg · tablet
Limited Use, Reason for Use code 475 requiredMarketed · checked November 18, 2026
StatusLimited Use, Reason for Use code 475 required
Write on scriptReason for Use code 475 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 475
Reason for Use code 475
For reducing the risk of overt hepatic encephalopathy (HE) recurrence (i.e., 2 or more episodes) in patients who are unable to achieve adequate control of HE recurrence with maximal tolerated dose of lactulose alone. Rifaximin should be used in combination with a maximal tolerated dose of lactulose. For patients not maintained on lactulose, the nature of the patient's intolerance to lactulose should be documented.
Coverage limit:
LU Authorization Period: Indefinite
No interchangeable product listed in the Ontario extract
Zaxine · DIN 02410702
Manufacturer: Salix Pharmaceuticals Inc.; listing date 2016-06-29
Health Canada: Marketed since 2013-11-07 · brand ZAXINE · ATC A07AA11 RIFAXIMIN · form Tablet · route Oral · ingredients RIFAXIMIN 550 MG · company Salix pharmaceuticals inc · schedule Prescription
Zaxine: Formulary list price $8.80 per unit (the source does not state the unit; exact figure $8.7985). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02410702)
Source record
DIN 02410702: Zaxine
Raw flags: sec12=Y, sec3=Y
Item: 081228164; group id 49; item number 0106; lccId 00264; manufacturer id SAL
Source form: Tab; strength: 550mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $8.7985; ministry $8.7985
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02410702
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=89537
Shortage status: not checked (no credentials)